Disease-Modifying Drugs for Adult-Onset Rheumatoid Arthritis
Maya N. Faison, Andrew M. Davis, Kimberly Trotter
Abstract
This article summarizes a 2022 clinical practice guideline on the use of disease-modifying antirheumatic drugs (DMARDs) for adults with rheumatoid arthritis from the European League Against Rheumatism (EULAR).
Topics & Concepts
MedicineRheumatoid arthritisRheumatismGuidelineAntirheumatic drugsDiseaseAntirheumatic AgentsClinical PracticeLeagueArthritisPhysical therapyIntensive care medicineInternal medicinePathologyPhysicsAstronomyRheumatoid Arthritis Research and TherapiesBiosimilars and Bioanalytical MethodsSystemic Lupus Erythematosus Research